Exercise reduces liver fat and improves surrogate measures of liver fibrosis in people with non-alcoholic fatty liver disease: Pooled analysis from randomised controlled trials

Introduction: Liver fibrosis is the key prognostic indicator for adverse outcomes in people living with non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Exercise training reduces liver fat and cardiovascular risk. While benefits appear independent of weight loss, the independent effects of exercise on liver fibrosis remains unknown. Evidence for the benefits of exercise on liver fibrosis is limited by small sample sizes due to recruitment barriers relating to serial liver biopsy.

Source: Journal of Science and Medicine in Sport - October 1, 2023 Category: Sports Medicine Authors: S. Keating, D. Cuthbertson, C. Pugh, J. Stine Tags: O2023SMA-228 Source Type: research